Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

340
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
340
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

2.9K
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
2.9K
Biostatistics: Overview01:20

Biostatistics: Overview

651
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
651
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

144
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
144
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.3K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

500
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
500

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards a decentralized future for open-science databases.

Nature genetics·2026
Same author

Disorders of Potassium.

Endocrinology and metabolism clinics of North America·2026
Same author

Proceedings of the 15<sup>th</sup> International Newborn Brain Conference: Neonatal Neurocritical Care, seizures, and continuous aEEG and /or EEG monitoring: Fota Island, Cork, Ireland, February 28<sup>th</sup> - March 2<sup>nd</sup> 2024.

Journal of neonatal-perinatal medicine·2025
Same author

Proceedings of the 15<sup>th</sup> International Newborn Brain Conference: Long-term outcome studies, developmental care, palliative care, ethical dilemmas, and challenging clinical scenarios in neonatal neurology: Fota Island, Cork, Ireland, February 28<sup>th</sup> - March 2<sup>nd</sup> 2024.

Journal of neonatal-perinatal medicine·2025
Same author

Proceedings of the 15<sup>th</sup> International Newborn Brain Conference: Neuro-imaging studies: Fota Island, Cork, Ireland, February 28<sup>th</sup> - March 2<sup>nd</sup> 2024.

Journal of neonatal-perinatal medicine·2025
Same author

A decentralized future for the open-science databases.

ArXiv·2025
Same journal

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026
Same journal

Rule-Based Algorithm to Identify Recurrent Non-Hodgkin Lymphoma in Electronic Health Data.

JCO clinical cancer informatics·2026
Same journal

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

JCO clinical cancer informatics·2026
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Dec 27, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.1K

Exploring Integrative Analysis Using the BioMedical Evidence Graph.

Adam Struck1, Brian Walsh1, Alexander Buchanan1

  • 1Biomedical Engineering, Oregon Health and Science University, Portland OR.

JCO Clinical Cancer Informatics
|February 26, 2020
PubMed
Summary
This summary is machine-generated.

The BioMedical Evidence Graph (BMEG) integrates diverse cancer biology data, enabling advanced analysis of mutations, gene expression, and drug responses. This comprehensive graph database facilitates novel discoveries in cancer research.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

Related Experiment Videos

Last Updated: Dec 27, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.1K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Cancer Genomics

Background:

  • Cancer biology research generates highly heterogeneous datasets, including RNA sequencing, copy number variations, DNA methylation, somatic mutations, pathology, and clinical outcomes.
  • Integrating these diverse data types is crucial for unlocking comprehensive insights into cancer biology and developing effective treatments.
  • Existing data integration frameworks often lack the capacity to handle complex relationships and dense feature vectors required for advanced analysis.

Purpose of the Study:

  • To introduce the BioMedical Evidence Graph (BMEG), a novel graph database and query engine designed for the discovery and analysis of cancer biology.
  • To establish a common framework that integrates heterogeneous cancer data, including molecular and clinical information, with reference knowledge bases.
  • To enable complex, cross-dataset analyses by providing a data model that supports intricate relationships and dense feature vectors.

Main Methods:

  • Developed the BioMedical Evidence Graph (BMEG), a graph database connecting sample-level molecular and clinical data to reference knowledge bases.
  • Integrated diverse data sources, including gene expression, mutation data, drug-response experiments, pathway databases, and literature-derived associations.
  • Implemented a graph query-based application programming interface (API) with client support for Python, Javascript, and R, and deployed a public server at bmeg.io.

Main Results:

  • Constructed a large-scale graph comprising over 41 million vertices and 57 million edges.
  • Demonstrated the utility of the BMEG system through various cross-dataset analyses, including mutation significance, drug-response machine learning, patient-level knowledge-base queries, and pathway analysis.
  • Compared to existing integrated graph systems, BMEG stands out for its scale and the unique types of data it makes available.

Conclusions:

  • The BioMedical Evidence Graph (BMEG) is a powerful and evolving resource that enables integrative analysis of complex cancer biology data.
  • The system facilitates advanced analytical tasks, including mutation significance assessment, predictive modeling for drug response, and comprehensive pathway analysis.
  • BMEG's unique scale and data integration capabilities offer significant advantages over other available integrated graph systems for cancer research.